Read + Share
Amedeo Smart
Independent Medical Education
Giovannoni G, Singer BA, Issard D, Jack D, et al. Durability of no evidence of disease activity-3 (NEDA-3) in patients receiving cladribine tablets: The CLARITY extension study. Mult Scler 2022;28:1219-1228.PMID: 34634968
Email
LinkedIn
Facebook
Twitter
Privacy Policy